Contact Us
Schwab Client Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Waldencast plc - Class A Ordinary Share (NQ:WALD)

0.9498 +0.0898 (+10.44%)
Delayed Quote Updated: 2:05 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Waldencast plc - Class A Ordinary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
Monday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Waldencast plc Announces First Half 2026 Financial Results
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act
From Waldencast plc
Via GlobeNewswire
Get insights into the top gainers and losers of Monday's pre-market session. ↗
Via Chartmill
News headline image
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act
From Waldencast plc
Via GlobeNewswire
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Approval Further Expands Obagi Medical’s Injectable Portfolio and Strengthens Its Position as a Leading Dermatological Megabrand 
From Waldencast plc
Via GlobeNewswire
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
Waldencast Announces Sale of Obagi Medical to Bridgepoint
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation 
From Waldencast plc
Via GlobeNewswire
Unusual volume stocks are being observed in Thursday's session. ↗
Via Chartmill
News headline image
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense 
From Waldencast plc
Via GlobeNewswire
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
News headline image
Waldencast announces conclusion of SEC investigation
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more resilient-looking skin 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
ProMD’s multi-location physician led network will participate in Obagi’s ALOHA Program as part of a structured evaluation of MagIQ and integrated skincare protocols to providers across multiple states 
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast Reports Q4 2025 and FY 2025 Financial Results
From Waldencast plc
Via GlobeNewswire
News headline image
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practices 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing... 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic... 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic entrepreneurs 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization 
From Waldencast plc
Via GlobeNewswire
News headline image
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers 
From Waldencast plc
Via GlobeNewswire
News headline image
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers 
From Waldencast plc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.